Gary Sender insider trades

Open-market stock purchases and sales by Gary Sender, Director at iBio, Inc, from SEC Form 4 filings since Feb 7, 2017.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -69%.

Recent trades

DateStockTradeValue
Oct 14, 2026IBIO iBio, IncBought (not open market)—
Aug 3, 2026APMD Apnimed, IncSold (not open market)—
Aug 3, 2026APMD Apnimed, IncBought (not open market)—
Aug 3, 2026APMD Apnimed, IncSold (not open market)—
Aug 3, 2026APMD Apnimed, IncBought (not open market)—
Jul 30, 2026APMD Apnimed, IncBought (not open market)—
Jun 22, 2026SDGR Schrodinger, IncBought (not open market)—
Jun 22, 2026SDGR Schrodinger, IncBought (not open market)—
May 14, 2026HRMY Harmony Biosciences Holdings, IncBought (not open market)—
Nov 20, 2025IBIO iBio, IncBought (not open market)—

Companies traded

  • IBIO iBio, Inc: 1 buy, last Oct 14, 2026
  • APMD Apnimed, Inc: other filings, last Aug 3, 2026
  • SDGR Schrodinger, Inc: 1 sale, last Jun 22, 2026
  • HRMY Harmony Biosciences Holdings, Inc: other filings, last May 14, 2026
  • NBRV Nabriva Therapeutics plc: 2 buys, 1 sale, last Feb 28, 2021

Get free alerts when Gary Sender files a new trade →